Latest Updates

12th Feb 2020
Report names JPMorgan “the world’s worst banker of climate change”. WEDNESDAY, FEBRUARY 12TH, 2020– Investors in JPMorgan ($JPM) who filed...
Read more
6th Feb 2020
As of Monday’s deadline for public comments on the SEC’s proposed restriction on shareholder rights, a broad group of investors has weighed in strongly against the SEC’s proposal to limit shareholders’ rights to file proposals for shareholders to...
Read more
22nd Nov 2019
Investor letter argues the companies are actively opposing standards that are good for business, shareholders, consumers, and the environment. NEW YORK, NY, FRIDAY, NOVEMBER 22, 2019 – In a letter...
Read more
18th Nov 2019
Report delivered at request of shareholders exposes serious lapses in human rights policies and a failure to demonstrate ‘respect for our inmates and detainees’. NEW YORK, NY, Monday,...
Read more
14th Nov 2019
2020 Shareholder Proposals at AbbVie, Amgen, Biogen Eli Lilly and Pfizer Ask for Study to Determine Feasibility of Incorporating Drug Pricing Risks into Exec Incentive Structures. NEW YORK...
Read more
5th Nov 2019
Agency caves to pressure from trade associations like the Business Roundtable, U.S. Chamber, and National Association of Manufacturers to the detriment of shareholders and the public interest....
Read more
24th Sep 2019
No mention of escalating gun violence by management at annual meeting of firearms manufacturer. Shareholders vow to continue pressing for improved safety measures.NEW YORK, NY...
Read more
19th Sep 2019
Citing human and economic tolls of climate change, investors release a new set of recommendations to speed de-carbonization. NEW YORK, NY, THURSDAY, SEPTEMBER 19TH, 2018 – In a...
Read more
12th Sep 2019
Citing concerns that NAFTA 2.0 will expand prescription drug monopoly protections and drive up drug prices by thwarting competition, investors urge lawmakers to vote ‘no’ on current agreement.NEW YORK, NY, THURSDAY...
Read more
11th Sep 2019
Shareholder engagement is leading to broad governance changes at opioid manufacturers, distributors and retailers, as detailed in progress report by Investors for Opioid Accountability.NEW YORK, NY - WEDNESDAY, SEPTEMBER 11TH, 2019...
Read more


Sign Up for our eNewsletter

* indicates required